KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to 0.5.

  • Thermo Fisher Scientific's Equity Ratio rose 150.4% to 0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5, marking a year-over-year increase of 150.4%. This contributed to the annual value of 0.51 for FY2024, which is 762.78% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Equity Ratio stood at 0.5, which was up 150.4% from 0.5 recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Equity Ratio registered a high of 0.54 during Q3 2021, and its lowest value of 0.43 during Q4 2021.
  • Its 5-year average for Equity Ratio is 0.48, with a median of 0.48 in 2024.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 1223.6% in 2021, then plummeted by 1682.8% in 2022.
  • Thermo Fisher Scientific's Equity Ratio (Quarter) stood at 0.43 in 2021, then increased by 5.52% to 0.45 in 2022, then grew by 4.45% to 0.47 in 2023, then increased by 7.63% to 0.51 in 2024, then fell by 2.79% to 0.5 in 2025.
  • Its Equity Ratio stands at 0.5 for Q3 2025, versus 0.5 for Q2 2025 and 0.5 for Q1 2025.